The cortical cholinergic system contributes to the top-down control of distraction: Evidence from patients with Parkinson's disease

Neuroimage. 2019 Apr 15:190:107-117. doi: 10.1016/j.neuroimage.2017.12.012. Epub 2017 Dec 19.

Abstract

Past animal and human studies robustly report that the cholinergic system plays an essential role in both top-down and bottom-up attentional control, as well as other aspects of cognition (see Ballinger et al., 2016 for a recent review). However, current understanding of how two major cholinergic pathways in the human brain (the basal forebrain-cortical pathway, and the brainstem pedunculopontine-thalamic pathway) contribute to specific cognitive functions remains somewhat limited. To address this issue, we examine how individual variation in the integrity of striatal-dopaminergic, thalamic-cholinergic, and cortical-cholinergic pathways (measured using Positron Emission Tomography in patients with Parkinson's disease) was associated with individual variation in the initial goal-directed focus of attention, the ability to sustain attentional performance over time, and the ability to avoid distraction from a highly-salient, but irrelevant, environmental stimulus. Compared to healthy controls, PD patients performed similarly in the precision of attention-dependent judgments of duration, and in sustaining attention over time. However, PD patients' performance was strikingly more impaired by the distractor. More critically, regression analyses indicated that only cortical-cholinergic integrity, not thalamic-cholinergic or striatal-dopaminergic integrity, made a specific contribution to the ability to resist distraction after controlling for the other variables. These results demonstrate that the basal forebrain cortical cholinergic system serves a specific role in executing top-down control to resist external distraction.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Acetylcholine / physiology*
  • Aged
  • Attention / physiology*
  • Basal Forebrain* / diagnostic imaging
  • Basal Forebrain* / metabolism
  • Basal Forebrain* / physiopathology
  • Cerebral Cortex* / diagnostic imaging
  • Cerebral Cortex* / metabolism
  • Cerebral Cortex* / physiopathology
  • Dopamine / physiology
  • Humans
  • Middle Aged
  • Neostriatum* / diagnostic imaging
  • Neostriatum* / metabolism
  • Neostriatum* / physiopathology
  • Neural Pathways / diagnostic imaging
  • Neural Pathways / metabolism
  • Neural Pathways / physiopathology
  • Parkinson Disease* / diagnostic imaging
  • Parkinson Disease* / metabolism
  • Parkinson Disease* / physiopathology
  • Positron-Emission Tomography*
  • Psychomotor Performance / physiology*
  • Thalamus* / diagnostic imaging
  • Thalamus* / metabolism
  • Thalamus* / physiopathology

Substances

  • Acetylcholine
  • Dopamine